This portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event. Archived information may be superseded by more recent information we have disclosed in later presentations, press releases, filings with the Securities and Exchange Commission or otherwise. Archived information may contain forward-looking statements. Actual results may materially differ based on several factors, including those described in the archived information, press releases and our filings with the SEC.
Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
- November 16, 2001
Targacept Honored as NCEITA’s 2001 Health/Pharmaceutical Company of the Year - November 15, 2001
Targacept to increase staff over 50 percent in 2002 - November 14, 2001
Targacept CEO Addresses Audience of 1,000 at Winston-Salem Chamber of Commerce Annual Meeting - July 30, 2001
Targacept Appoints Tamar Howson and Mark Skaletsky to Its Board of Directors - June 25, 2001
Targacept, Inc. Presents at BIO 2001 International Investor and Partnering Forum - June 05, 2001
Geoffrey Dunbar, M.D., Joins Targacept as Vice President, Clinical Development - May 17, 2001
Targacept Names Patrick Lippiello, Ph.D. Vice President, Scientific and Program Development - March 08, 2001
Targacept Announces Joint Development Agreement with Dr. Falk Pharma GmbH for Therapy to Treat Ulcerative Colitis